Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 1
2011 1
2013 3
2014 1
2015 3
2016 1
2017 2
2019 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
18FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysis.
Groheux D, Martineau A, Teixeira L, Espié M, de Cremoux P, Bertheau P, Merlet P, Lemarignier C. Groheux D, et al. Among authors: martineau a. Breast Cancer Res. 2017 Jan 5;19(1):3. doi: 10.1186/s13058-016-0793-2. Breast Cancer Res. 2017. PMID: 28057031 Free PMC article.
Calibration test of PET scanners in a multi-centre clinical trial on breast cancer therapy monitoring using 18F-FLT.
Bouchet F, Geworski L, Knoop BO, Ferrer L, Barriolo-Riedinger A, Millardet C, Fourcade M, Martineau A, Belly-Poinsignon A, Djoumessi F, Tendero K, Keros L, Montoya F, Mesleard C, Martin AL, Lacoeuille F, Couturier O. Bouchet F, et al. Among authors: martineau a. PLoS One. 2013;8(3):e58152. doi: 10.1371/journal.pone.0058152. Epub 2013 Mar 13. PLoS One. 2013. PMID: 23516443 Free PMC article.
Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with 18F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients.
Lemarignier C, Martineau A, Teixeira L, Vercellino L, Espié M, Merlet P, Groheux D. Lemarignier C, et al. Among authors: martineau a. Eur J Nucl Med Mol Imaging. 2017 Jul;44(7):1145-1154. doi: 10.1007/s00259-017-3641-4. Epub 2017 Feb 10. Eur J Nucl Med Mol Imaging. 2017. PMID: 28188325 Clinical Trial.
Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?
Groheux D, Majdoub M, Tixier F, Le Rest CC, Martineau A, Merlet P, Espié M, de Roquancourt A, Hindié E, Hatt M, Visvikis D. Groheux D, et al. Among authors: martineau a. Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1682-1691. doi: 10.1007/s00259-015-3110-x. Epub 2015 Jul 4. Eur J Nucl Med Mol Imaging. 2015. PMID: 26140849 Free PMC article.
18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort.
Hatt M, Majdoub M, Vallières M, Tixier F, Le Rest CC, Groheux D, Hindié E, Martineau A, Pradier O, Hustinx R, Perdrisot R, Guillevin R, El Naqa I, Visvikis D. Hatt M, et al. Among authors: martineau a. J Nucl Med. 2015 Jan;56(1):38-44. doi: 10.2967/jnumed.114.144055. Epub 2014 Dec 11. J Nucl Med. 2015. PMID: 25500829 Free article.
14 results